• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性高钙尿症和肾结石与 CYP24A1 酶多态性相关的婴儿:病例报告。

AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.

机构信息

Department of Pediatrics, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.

出版信息

Acta Clin Croat. 2022 Feb;60(3):544-547. doi: 10.20471/acc.2021.60.03.27.

DOI:10.20471/acc.2021.60.03.27
PMID:35282483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8907965/
Abstract

CYP24A1 is an enzyme that inactivates vitamin D and encodes vitamin D 24-hydroxylase. Mutations in this enzyme have been linked with idiopathic infantile hypercalcemia, nephrolithiasis, and nephrocalcinosis. Genetic testing for this mutation should be considered in the presence of calciuria, elevated serum calcium, elevated 1,25- dihydroxyvitamin D, and suppressed parathyroid hormone. We present a previously healthy eight-month-old male infant with macrohematuria, hypercalciuria (6 mg/kg/24 h), albuminuria (54 mg/24 h) and left-sided nephrolithiasis found on urinary tract ultrasound. The values of alpha 1 microglobulin, parathyroid hormone, vitamin D, serum electrolytes, amino acids, glycols, oxalates and citrates in urine, as well as coagulation tests were normal. Genetic testing excluded suspected Dent's disease but confirmed heterozygous missense variant CYP24A1 c.469C>T, p.(Arg157Trp) classified as polymorphism. He was treated with hydrochlorothiazide and potassium citrate. Children presenting with hypercalcemia, hypercalciuria and nephrolithiasis should be tested because of the importance of recognition, genetic diagnosis and proper treatment of CYP24A1 mutations that can present with a wide range of phenotypic presentations, from asymptomatic to chronic renal disease.

摘要

CYP24A1 是一种使维生素 D 失活并编码维生素 D24-羟化酶的酶。该酶的突变与特发性婴儿高钙血症、肾结石和肾钙质沉着症有关。在存在钙尿症、血清钙升高、1,25-二羟维生素 D 升高和甲状旁腺激素抑制的情况下,应考虑对此突变进行基因检测。我们介绍了一名之前健康的 8 个月大男婴,他出现了肉眼血尿、高钙尿症(6mg/kg/24h)、蛋白尿(54mg/24h)和左侧肾结石,在尿路超声检查中发现。尿中α1微球蛋白、甲状旁腺激素、维生素 D、血清电解质、氨基酸、糖、草酸盐和柠檬酸盐以及凝血试验值均正常。基因检测排除了疑似 Dent 病,但证实杂合错义变体 CYP24A1 c.469C>T,p.(Arg157Trp)为多态性。他接受了氢氯噻嗪和柠檬酸钾治疗。由于认识、遗传诊断和适当治疗 CYP24A1 突变的重要性,应检测出现高钙血症、高钙尿症和肾结石的儿童,这些突变可表现出广泛的表型表现,从无症状到慢性肾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6485/8907965/2250694c3c0a/acc-60-544-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6485/8907965/ace3a7158162/acc-60-544-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6485/8907965/2250694c3c0a/acc-60-544-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6485/8907965/ace3a7158162/acc-60-544-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6485/8907965/2250694c3c0a/acc-60-544-f2.jpg

相似文献

1
AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.特发性高钙尿症和肾结石与 CYP24A1 酶多态性相关的婴儿:病例报告。
Acta Clin Croat. 2022 Feb;60(3):544-547. doi: 10.20471/acc.2021.60.03.27.
2
Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.CYP24A1 基因(维生素 D24-羟化酶基因)的功能丧失性突变可导致长期存在的高钙尿性肾结石和肾钙质沉着症。
J Urol. 2013 Aug;190(2):552-7. doi: 10.1016/j.juro.2013.02.3188. Epub 2013 Mar 5.
3
Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.因 CYP24A1 突变导致维生素 D 24-羟化作用受损的患者的肾功能和阳光暴露的影响。
Am J Kidney Dis. 2015 Jan;65(1):122-6. doi: 10.1053/j.ajkd.2014.06.037. Epub 2014 Nov 4.
4
Idiopathic Infantile Hypercalcemia, Presenting in Adulthood--No Longer Idiopathic Nor Infantile: Two Case Reports and Review.成年期出现的特发性婴儿高钙血症——不再是特发性或婴儿期疾病:两例报告及文献复习
Conn Med. 2015 Nov-Dec;79(10):593-7.
5
A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.一种与高钙血症、肾结石和低骨量临床症状相关的新型CYP24A1基因型。
Urolithiasis. 2017 Jun;45(3):291-294. doi: 10.1007/s00240-016-0923-4. Epub 2016 Sep 17.
6
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.CYP24A1突变杂合携带者的钙和骨稳态:一项横断面研究。
Bone. 2015 Dec;81:89-96. doi: 10.1016/j.bone.2015.06.018. Epub 2015 Jun 25.
7
Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.两名患有肾钙质沉着症的成年兄弟中与维生素D羟化酶(CYP24A1)相关的高钙血症的不一致临床病程。
Kidney Blood Press Res. 2015;40(5):443-51. doi: 10.1159/000368520. Epub 2015 Aug 22.
8
CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.在加拿大一组高钙血症或高钙尿症儿童中,CYP24A1和SLC34A1致病变体并不常见。
Horm Res Paediatr. 2021;94(3-4):124-132. doi: 10.1159/000517548. Epub 2021 Jul 28.
9
1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.1,25-(OH)2D-24 羟化酶(CYP24A1)缺陷导致肾结石。
Clin J Am Soc Nephrol. 2013 Apr;8(4):649-57. doi: 10.2215/CJN.05360512. Epub 2013 Jan 4.
10
Biallelic and monoallelic pathogenic variants in CYP24A1 and SLC34A1 genes cause idiopathic infantile hypercalcemia.CYP24A1 和 SLC34A1 基因中的双等位基因和单等位基因致病性变异导致特发性婴儿高钙血症。
Orphanet J Rare Dis. 2024 Mar 19;19(1):126. doi: 10.1186/s13023-024-03135-8.

本文引用的文献

1
Vitamin D and Calcium Homeostasis in Infants with Urolithiasis.婴儿尿路结石症中维生素 D 和钙的动态平衡。
Adv Exp Med Biol. 2019;1133:75-81. doi: 10.1007/5584_2018_310.
2
A Case Report of Compound Heterozygous CYP24A1 Mutations Leading to Nephrolithiasis Successfully Treated with Ketoconazole.一例由复合杂合性CYP24A1突变导致肾结石并成功用酮康唑治疗的病例报告
Case Rep Nephrol Dial. 2017 Dec 18;7(3):167-171. doi: 10.1159/000485243. eCollection 2017 Sep-Dec.
3
Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
氢氯噻嗪的使用与非黑色素瘤皮肤癌风险:来自丹麦的全国病例对照研究。
J Am Acad Dermatol. 2018 Apr;78(4):673-681.e9. doi: 10.1016/j.jaad.2017.11.042. Epub 2017 Dec 4.
4
Etiologic risk factors and vitamin D receptor gene polymorphisms in under one-year-old infants with urolithiasis.一岁以下尿路结石患儿的病因危险因素和维生素 D 受体基因多态性。
Urolithiasis. 2018 Aug;46(4):349-356. doi: 10.1007/s00240-017-1009-7. Epub 2017 Oct 30.
5
The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations.实验室检测在慢性肾脏病检测与分类中的作用:国家建议
Biochem Med (Zagreb). 2017 Feb 15;27(1):153-176. doi: 10.11613/BM.2017.019.
6
CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.CYP24A1 基因突变在高钙血症患者队列中的研究:隐性特征的证据。
J Clin Endocrinol Metab. 2015 Oct;100(10):E1343-52. doi: 10.1210/jc.2014-4387. Epub 2015 Jul 27.
7
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.CYP24A1突变杂合携带者的钙和骨稳态:一项横断面研究。
Bone. 2015 Dec;81:89-96. doi: 10.1016/j.bone.2015.06.018. Epub 2015 Jun 25.
8
Urolithiasis in infants: evaluation of risk factors.婴儿尿路结石:危险因素评估。
World J Urol. 2013 Oct;31(5):1117-22. doi: 10.1007/s00345-012-0828-y. Epub 2012 Jan 19.
9
Genetic causes of hypercalciuric nephrolithiasis.高钙尿性肾结石的遗传病因。
Pediatr Nephrol. 2009 Dec;24(12):2321-32. doi: 10.1007/s00467-008-0807-0. Epub 2008 Apr 30.